KalVista Pharmaceuticals
KALV
KALV
18 hedge funds and large institutions have $54.1M invested in KalVista Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 20 → 18 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
18
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$661K | |
| 2 | +$6.75K | |
| 3 | +$4K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.55K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$720 |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$86K | |
| 3 | -$5.85K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.45K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$39 |